Regulatory Update: What Changes to MiFIR and MiFID II Mean for Compliance Teams
By: William Kolkey and Walther Navarrete Amendments to MiFIR and MiFID II went into force on March 28, beginning the process of establishing a
By: William Kolkey and Walther Navarrete Amendments to MiFIR and MiFID II went into force on March 28, beginning the process of establishing a
By: Leith Dennis As artificial intelligence becomes an increasingly hot topic and a popular tool to solve certain business problems efficiently, we are frequently
By: Alastair Whitehair When it comes to regulatory reporting, firms are often faced with a puzzling dilemma: Why is it so difficult to achieve
By: Stuart Billingham At the end of November, Droit and Goldman Sachs hosted an educational panel session on the importance of consensus around complex
Industry-trusted solutions combine to provide unparalleled reporting capabilities in advance of complex global regulatory rewrites Droit, a technology firm at the forefront of computational
Unique transaction identifiers (UTIs) have been a key element of OTC derivatives reporting for nearly a decade. When used consistently, UTIs allow reported transactions to